These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 22286802

  • 1. Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria.
    Lewandowski KC, Cajdler-Luba A, Bieńkiewicz M, Lewiński A.
    Neuro Endocrinol Lett; 2011; 32(6):847-56. PubMed ID: 22286802
    [Abstract] [Full Text] [Related]

  • 2. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
    Lewandowski KC, Cajdler-Łuba A, Salata I, Bieńkiewicz M, Lewiński A.
    Endokrynol Pol; 2011; 62(2):120-8. PubMed ID: 21528473
    [Abstract] [Full Text] [Related]

  • 3. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM, Wass JA, McCarthy MI, Franks S.
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [Abstract] [Full Text] [Related]

  • 4. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
    Blank SK, McCartney CR, Helm KD, Marshall JC.
    Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
    [Abstract] [Full Text] [Related]

  • 6. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
    Ma CS, Lin Y, Zhang CH, Xu H, Li YF, Zhang SC, Tan Y, Quan S, Xing FQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
    [Abstract] [Full Text] [Related]

  • 7. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S, Taylor AE, Martin KA, Welt CK, Adams JM, Hall JE.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [Abstract] [Full Text] [Related]

  • 8. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M, Liz-Lestón J, Lado-Abeal J.
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [Abstract] [Full Text] [Related]

  • 9. Pituitary-ovarian response to the gonadotrophin-releasing hormone-agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma.
    Fulghesu AM, Angioni S, Belosi C, Apa R, Selvaggi L, Ciampelli M, Iuculano A, Melis GB, Lanzone A.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):396-401. PubMed ID: 16918963
    [Abstract] [Full Text] [Related]

  • 10. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
    McCartney CR, Eagleson CA, Marshall JC.
    Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
    [Abstract] [Full Text] [Related]

  • 11. Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.
    Köninger A, Koch L, Edimiris P, Enekwe A, Nagarajah J, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B.
    Arch Gynecol Obstet; 2014 Nov; 290(5):1023-30. PubMed ID: 24961320
    [Abstract] [Full Text] [Related]

  • 12. Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.
    Hayes FJ, Taylor AE, Martin KA, Hall JE.
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2343-9. PubMed ID: 9661606
    [Abstract] [Full Text] [Related]

  • 13. LH as a diagnostic criterion for polycystic ovary syndrome in patients with WHO II oligo/amenorrhoea.
    Hendriks ML, Brouwer J, Hompes PG, Homburg R, Lambalk CB.
    Reprod Biomed Online; 2008 Jun; 16(6):765-71. PubMed ID: 18549684
    [Abstract] [Full Text] [Related]

  • 14. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA, Gingrich MB, Pastor CL, Arora TK, Burt CM, Evans WS, Marshall JC.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [Abstract] [Full Text] [Related]

  • 15. [Different types of menstrual cycle and their significance in Chinese women diagnosed with polycystic ovary syndrome according to the Rotterdam consensus criteria].
    Xu XH, Tan YC, Shi YH, Wang B, Ju XQ, Zheng QM, Hao CF, Chen ZJ.
    Zhonghua Yi Xue Za Zhi; 2009 Oct 13; 89(37):2604-6. PubMed ID: 20137675
    [Abstract] [Full Text] [Related]

  • 16. Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome.
    Katsikis I, Karkanaki A, Misichronis G, Delkos D, Kandaraki EA, Panidis D.
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun 13; 156(2):181-5. PubMed ID: 21353371
    [Abstract] [Full Text] [Related]

  • 17. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
    Blank SK, McCartney CR, Marshall JC.
    Hum Reprod Update; 2006 Jun 13; 12(4):351-61. PubMed ID: 16670102
    [Abstract] [Full Text] [Related]

  • 18. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L, Hall JE, Potau N, Carrascosa A, Prat N, Taylor AE.
    J Clin Endocrinol Metab; 1996 Nov 13; 81(11):4103-7. PubMed ID: 8923867
    [Abstract] [Full Text] [Related]

  • 19. Insulin modulation of luteinizing hormone secretion in normal female volunteers and lean polycystic ovary syndrome patients.
    Moret M, Stettler R, Rodieux F, Gaillard RC, Waeber G, Wirthner D, Giusti V, Tappy L, Pralong FP.
    Neuroendocrinology; 2009 Nov 13; 89(2):131-9. PubMed ID: 18832802
    [Abstract] [Full Text] [Related]

  • 20. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
    Arroyo A, Laughlin GA, Morales AJ, Yen SS.
    J Clin Endocrinol Metab; 1997 Nov 13; 82(11):3728-33. PubMed ID: 9360532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.